• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在膀胱癌细胞系中,免疫检查点配体 CD276(B7-H3)的表达升高与细胞增殖呈负相关。

Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.

机构信息

Department of Urology, University of Tuebingen Hospital, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany.

Center for Medical Research, University of Tuebingen Hospital, Waldhoernlestr. 22, 72072 Tuebingen, Germany.

出版信息

Int J Mol Sci. 2022 Apr 29;23(9):4969. doi: 10.3390/ijms23094969.

DOI:10.3390/ijms23094969
PMID:35563359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9100984/
Abstract

UNLABELLED

The cell surface molecule CD276 (B7-H3) is an immune checkpoint antigen. The elevated expression of CD276 on tumors contributes to the suppression of anti-tumor T-cell responses and correlates with poor prognosis.

METHODS

The expression of CD276 was explored in vitro on eight urothelial carcinoma cell lines (UM-UC) in comparison to eight normal urothelial cells (NUCs) by RT-qPCR, Western blotting, and flow cytometry. Cell proliferation was enumerated over consecutive passages. The expression of cancer stem cell markers CD24 and CD44, cytokeratins, and vimentin was investigated by immunofluorescence. The expression of CD276 in bladder tumor samples and metastases was explored by immunohistochemistry.

RESULTS

Expression of CD276 on cell surfaces was elevated on UM-UCs when compared to NUCs. In UM-UCs, CD276 transcripts correlated moderately positive with CD276 protein expression (ρ = 0.660) and strongly positive with CD276 surface-expression (ρ = 0.810). CD276 mRNA expression (ρ = -0.475) and CD276 protein expression (ρ = -0.417) had a significant negative correlation with proliferation, while a significant correlation between proliferation and cell surface expression was not observed in UM-UCs.

CONCLUSION

The expression of CD276 on UM-UC bladder tumor cell surfaces is elevated. Slow proliferating UM-UC cells express more CD276 mRNA and protein than fast proliferating cells. In patients, slow proliferating CD276 tumor (stem) cells may evade immune surveillance. However, cancer therapy targeting CD276 may be effective in the treatment of slow proliferating tumor cells.

摘要

未加标签

细胞表面分子 CD276(B7-H3)是一种免疫检查点抗原。肿瘤中 CD276 的高表达有助于抑制抗肿瘤 T 细胞反应,并与预后不良相关。

方法

通过 RT-qPCR、Western blot 和流式细胞术,在 8 种尿路上皮癌细胞系(UM-UC)与 8 种正常尿路上皮细胞(NUC)中研究 CD276 的表达。通过连续传代计数细胞增殖。通过免疫荧光法研究癌症干细胞标志物 CD24 和 CD44、细胞角蛋白和波形蛋白的表达。通过免疫组织化学法研究膀胱肿瘤样本和转移灶中 CD276 的表达。

结果

与 NUCs 相比,UM-UC 细胞表面 CD276 的表达升高。在 UM-UC 中,CD276 转录物与 CD276 蛋白表达呈中度正相关(ρ=0.660),与 CD276 表面表达呈强正相关(ρ=0.810)。CD276 mRNA 表达(ρ=-0.475)和 CD276 蛋白表达(ρ=-0.417)与增殖呈显著负相关,而在 UM-UC 中未观察到增殖与细胞表面表达之间的显著相关性。

结论

UM-UC 膀胱肿瘤细胞表面 CD276 的表达升高。增殖缓慢的 UM-UC 细胞比增殖快速的细胞表达更多的 CD276 mRNA 和蛋白。在患者中,增殖缓慢的 CD276 肿瘤(干细胞)细胞可能逃避免疫监视。然而,针对 CD276 的癌症治疗可能对治疗增殖缓慢的肿瘤细胞有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/3cf7b3a1d2f2/ijms-23-04969-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/8662b5479b02/ijms-23-04969-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/2c0bc6c90c7a/ijms-23-04969-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/ba972e3710bd/ijms-23-04969-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/b3e74d89fccb/ijms-23-04969-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/cb76434055b4/ijms-23-04969-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/a79980e15cb6/ijms-23-04969-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/b080a2a3195b/ijms-23-04969-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/a23a97ae5f5e/ijms-23-04969-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/3cf7b3a1d2f2/ijms-23-04969-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/8662b5479b02/ijms-23-04969-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/2c0bc6c90c7a/ijms-23-04969-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/ba972e3710bd/ijms-23-04969-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/b3e74d89fccb/ijms-23-04969-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/cb76434055b4/ijms-23-04969-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/a79980e15cb6/ijms-23-04969-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/b080a2a3195b/ijms-23-04969-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/a23a97ae5f5e/ijms-23-04969-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d12/9100984/3cf7b3a1d2f2/ijms-23-04969-g009.jpg

相似文献

1
Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.在膀胱癌细胞系中,免疫检查点配体 CD276(B7-H3)的表达升高与细胞增殖呈负相关。
Int J Mol Sci. 2022 Apr 29;23(9):4969. doi: 10.3390/ijms23094969.
2
Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma.CD276 在尿路上皮癌中的免疫检查点配体表达模式。
BMC Urol. 2021 Apr 12;21(1):60. doi: 10.1186/s12894-021-00829-0.
3
CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?CD24:体外膀胱癌类器官广泛扩增潜能的标志物?
Int J Mol Sci. 2022 May 13;23(10):5453. doi: 10.3390/ijms23105453.
4
Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.膀胱尿路上皮癌中免疫检查点相关分子的信使核糖核酸表达与蛋白质表达的相关性:一项回顾性研究。
Urol Oncol. 2017 May;35(5):257-263. doi: 10.1016/j.urolonc.2017.01.014. Epub 2017 Mar 11.
5
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.CD276(B7-H3)在肾上腺皮质癌中的表达的临床病理和预后特征。
Dis Markers. 2020 Jan 11;2020:5354825. doi: 10.1155/2020/5354825. eCollection 2020.
6
CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells.CD276(B7-H3)在晚期内皮祖细胞的增殖和血管生成功能分化中维持增殖和调节分化。
Stem Cells. 2019 Mar;37(3):382-394. doi: 10.1002/stem.2944. Epub 2018 Nov 28.
7
Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets.成神经管细胞瘤中免疫检查点基因的数字表达谱鉴定 CD24 和 CD276 为潜在的免疫治疗靶点。
Front Immunol. 2023 Feb 7;14:1062856. doi: 10.3389/fimmu.2023.1062856. eCollection 2023.
8
Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.雌激素受体α和β在调节尿路上皮细胞增殖中的作用。
Endocr Relat Cancer. 2008 Mar;15(1):351-64. doi: 10.1677/erc.1.01255.
9
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.MTHFD2 是一种潜在的致癌基因,因为它与膀胱癌的不良预后和高水平的免疫浸润密切相关。
BMC Cancer. 2022 May 17;22(1):556. doi: 10.1186/s12885-022-09606-0.
10
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.多组学分析泛癌中的 CD276,揭示其在胶质母细胞瘤和其他主要癌症类型中的临床预后价值。
BMC Cancer. 2023 Jan 30;23(1):102. doi: 10.1186/s12885-023-10575-1.

引用本文的文献

1
Preliminary screening of urinary host protein biomarkers for Schistosomiasis haematobium: A proteome profiling study identifying candidate diagnostic targets in school-aged children.埃及血吸虫病尿液宿主蛋白质生物标志物的初步筛选:一项蛋白质组分析研究,确定学龄儿童中的候选诊断靶点。
PLoS Negl Trop Dis. 2025 Aug 25;19(8):e0013429. doi: 10.1371/journal.pntd.0013429. eCollection 2025 Aug.
2
Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy.靶向B7-H3可增强基于新抗原的癌症疫苗与放射治疗联合使用时的疗效。
NPJ Vaccines. 2025 Apr 21;10(1):80. doi: 10.1038/s41541-025-01132-x.
3

本文引用的文献

1
CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1.CD276 是招募巨噬细胞进入肿瘤的重要因子,也是 PAI-1 的上游调节因子。
Sci Rep. 2021 Jul 21;11(1):14849. doi: 10.1038/s41598-021-94360-9.
2
CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance.CD276 表达使鳞状细胞癌干细胞能够逃避免疫监视。
Cell Stem Cell. 2021 Sep 2;28(9):1597-1613.e7. doi: 10.1016/j.stem.2021.04.011. Epub 2021 May 3.
3
Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma.
Patient-derived bladder cancer organoids show stable transcript expression along cultivation.
患者来源的膀胱癌类器官在培养过程中表现出稳定的转录表达。
World J Urol. 2024 Aug 7;42(1):468. doi: 10.1007/s00345-024-05182-z.
4
CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma.CTHRC1 是与头颈部鳞状细胞癌免疫浸润相关的预后生物标志物。
BMC Oral Health. 2024 Jun 27;24(1):742. doi: 10.1186/s12903-024-04525-x.
5
Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer.非肌层浸润性膀胱癌中免疫检查点基因表达与卡介苗反应
Transl Oncol. 2024 Aug;46:102003. doi: 10.1016/j.tranon.2024.102003. Epub 2024 Jun 4.
6
Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer.膀胱癌铂类耐药相关基因特征的鉴定及其预后和免疫分析
Front Genet. 2023 Jan 26;14:1062060. doi: 10.3389/fgene.2023.1062060. eCollection 2023.
CD276 在尿路上皮癌中的免疫检查点配体表达模式。
BMC Urol. 2021 Apr 12;21(1):60. doi: 10.1186/s12894-021-00829-0.
4
The Role of CD276 in Cancers.CD276在癌症中的作用。
Front Oncol. 2021 Mar 26;11:654684. doi: 10.3389/fonc.2021.654684. eCollection 2021.
5
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.在癌症免疫治疗中,靶向肿瘤免疫微环境优于阻断免疫检查点。
Signal Transduct Target Ther. 2021 Feb 20;6(1):72. doi: 10.1038/s41392-020-00449-4.
6
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.用于治疗膀胱癌的免疫检查点抑制剂
Cancers (Basel). 2021 Jan 3;13(1):131. doi: 10.3390/cancers13010131.
7
Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling.CD276基因沉默通过调节整合素信号传导抑制肺癌进展。
J Thorac Dis. 2020 May;12(5):2137-2145. doi: 10.21037/jtd.2020.04.41.
8
Direct trafficking pathways from the Golgi apparatus to the plasma membrane.从高尔基体到质膜的直接转运途径。
Semin Cell Dev Biol. 2020 Nov;107:112-125. doi: 10.1016/j.semcdb.2020.04.001. Epub 2020 Apr 13.
9
Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.细胞质 B7-H3 表达和膜 EpCAM 表达与肾透明细胞癌患者的高分级和生存结局相关。
Ann Diagn Pathol. 2020 Jun;46:151483. doi: 10.1016/j.anndiagpath.2020.151483. Epub 2020 Feb 25.
10
B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A.B7-H3通过调控细胞周期蛋白磷酸酶25A(CDC25A)促进结肠癌细胞的细胞周期介导的化疗耐药性。
J Cancer. 2020 Feb 3;11(8):2158-2170. doi: 10.7150/jca.37255. eCollection 2020.